Literature DB >> 8793304

Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.

L M Camacho1, N G Bartholomew, G W Joe, M A Cloud, D D Simpson.   

Abstract

HIV risk behavior was examined in relation to gender and cocaine use among a sample of 327 daily opioid users in methadone maintenance treatment. Women and cocaine users tended to be at higher risk than men and non-users prior to treatment entry. Significant reductions in both injection and sex-related risks occurred from intake to months 3 and 6 of treatment; HIV risks were also reduced among the subsample of clients who continued to inject drugs during treatment. The rate of HIV risk reduction was similar for both cocaine and non-cocaine users, but women had lower rates of risk reduction than men in terms of injecting with used equipment and number of sex partners. Measures of risk behavior at month 6 of treatment showed that women used 'dirty works' more often than men, and cocaine users injected more frequently and had more sex partners than non-cocaine users. Study outcomes highlight the need for specialized interventions targeting women and cocaine-using opioid addicts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793304     DOI: 10.1016/0376-8716(96)01235-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

1.  Impact of interim methadone maintenance on HIV risk behaviors.

Authors:  Monique E Wilson; Robert P Schwartz; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

2.  Risk factors in the relationship between gender and crack/cocaine.

Authors:  C W Lejuez; Marina A Bornovalova; Elizabeth K Reynolds; Stacey B Daughters; John J Curtin
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

3.  Longitudinal HIV risk behavior among the Drug Abuse Treatment Outcome Studies (DATOS) adult sample.

Authors:  Debra A Murphy; Mary-Lynn Brecht; Diane Herbeck; Elizabeth Evans; David Huang; Yih-Ing Hser
Journal:  Eval Rev       Date:  2008-02

Review 4.  Women who use injection drugs: the social context of risk.

Authors:  E M Whynot
Journal:  CMAJ       Date:  1998-08-25       Impact factor: 8.262

5.  Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E Oʼgrady; Devang Gandhi; Jerome H Jaffe
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

Review 6.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

7.  Patients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care.

Authors:  P Todd Korthuis; Jessica Gregg; Wendy E Rogers; Dennis McCarty; Christina Nicolaidis; Joshua Boverman
Journal:  J Addict Med       Date:  2010-12       Impact factor: 3.702

8.  HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.

Authors:  Christina S Meade; Leah J McDonald; Roger D Weiss
Journal:  Am J Addict       Date:  2009 Jul-Aug

9.  Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.

Authors:  Monique E Wilson; Timothy W Kinlock; Michael S Gordon; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2012 Sep-Oct

10.  Preventing HIV in injection drug users: choosing the best mix of interventions for the population.

Authors:  Amy R Wilson; James G Kahn
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.